CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway. - Wikidata - wikimedia - TriplyDB

CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway.

CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway.

http://www.wikidata.org/entity/Q33909085

about

Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221 Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function Recombinant R-spondin2 and Wnt3a up- and down-regulate novel target genes in C57MG mouse mammary epithelial cells Chemokine CXCL16 expression suppresses migration and invasiveness and induces apoptosis in breast cancer cells.The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiation The role of chemoattractant receptors in shaping the tumor microenvironment.Involvement of mTOR in CXCL12 mediated T cell signaling and migration.The emerging role of CXC chemokines and their receptors in cancer.Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population.The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cells.CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.Expression analysis and clinical significance of CXCL16/CXCR6 in patients with bladder cancer.Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the G1/S phase transition.Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis.CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering Changing the energy of an immune response Chemokines and chemokine receptors as promoters of prostate cancer growth and progression.CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines.CXCL16 regulates cisplatin-induced acute kidney injury.International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.Translation initiation: a critical signalling node in cancer.Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity.Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior.CXCR6: the role of environment in tumor progression. Challenges for therapy.Therapeutic potential of cancer stem cells.Luteolin induces apoptosis in vitro through suppressing the MAPK and PI3K signaling pathways in gastric cancer.Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration.Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis Downregulation of cancer stem cell properties via mTOR signaling pathway inhibition by rapamycin in nasopharyngeal carcinoma.MEK inhibitor diminishes nasopharyngeal carcinoma (NPC) cell growth and NPC-induced osteoclastogenesis via modulating CCL2 and CXCL16 expressions.Blockade of CXCR6 reduces invasive potential of gastric cancer cells through inhibition of AKT signaling.Blockade of the CXCR6 signaling inhibits growth and invasion of hepatocellular carcinoma cells through inhibition of the VEGF expression.Escin suppresses migration and invasion involving the alteration of CXCL16/CXCR6 axis in human gastric adenocarcinoma AGS cells.

P2860

Q24631381-DA272D01-3ECC-49DE-B614-B21DC3F1CC2B Q26799114-D7C6B528-BD22-474F-B0A0-5EC92DC98E4C Q28246944-F8BA8948-89C4-4161-AD98-3C8D83D63D4C Q28478701-C47B0605-3398-4AAA-A724-6DD4CA461F28 Q30412948-24EB6BA8-1F5A-4351-A310-D612F9C6189D Q30438926-FCB8D74F-4362-4D5E-8212-CDF308942400 Q33579657-368CE480-032A-4877-A204-C6DEBBCE7D22 Q33802647-BDF43940-1A5A-47BF-BBC2-3CE9BB57B372 Q33993124-6B155527-2A2D-48BF-A9D8-6D4B68D47510 Q34023880-F365146D-0BA4-499F-876E-3CB2E675BA7B Q34263645-883270FB-EC6D-4E41-913D-E31CCEBA0FBD Q34308937-FA53B897-1963-4827-9DC5-34C58D8F59AC Q34345248-90C837CC-2A0B-4085-8A8A-7955B26BDA5C Q34496096-7B4B67F2-92B4-4105-8B5E-9AEB3D86C7E9 Q35181573-E3A5F47F-73FD-4B87-AD51-0EAD7AFC2DD7 Q35645484-21A3DA53-982A-43A7-B58B-D124D7F37D03 Q35987292-FB5A550A-3567-4359-95A1-A2DFD7D2ECEC Q36475434-471E3B94-8C4B-4CFC-855C-5966DB7C3AEB Q36592493-74B67476-457F-4CA4-B93F-F608B1FF567E Q36831102-EBD62B1B-0134-4851-9966-88F9CCB7E5FB Q36916482-759722BA-2D30-48BA-ACCB-DFBFF457E4CE Q37021691-C0AB8C5C-528F-4955-AC07-4EF3385751CA Q37078475-85BF48AA-580D-423F-9237-4130DEA175C2 Q37079121-D1884CE7-A39D-4B6D-A4B7-F4EBE2A6F88D Q37115310-EC8CE112-DC51-4327-BF5A-4988C86DB89F Q37362481-04B83EDE-FF8E-4A17-ACBD-65803F7BD0B8 Q37432097-3D7C417A-BCF7-4647-99BD-989870A9BD39 Q37586472-928F04BF-4A35-44CD-9C72-771BAA3A5185 Q37650715-48A86414-5669-4C2A-8E90-E5F73C988D29 Q37970017-DAA1D504-9D69-44D6-841B-915DA047D260 Q38017150-B8F54C88-0CFF-4E02-A7F2-B691AFC8668A Q38446739-8856C56F-92AA-4245-A62D-44D1CD769532 Q38695467-227B54F0-A13B-4570-8BDA-56DF910B1E3A Q38728052-09D8EC40-1B62-418C-BABE-049EFC863CCF Q38808703-07D1669B-9A56-44A9-916F-21CCF48DD3DC Q38850277-89E25E87-4C59-443F-9CFA-8E9DF48BD529 Q38865662-968ACB62-BDF8-4FBF-881A-2DB110CBC1BA Q38881161-CC1D8466-D52E-4F7A-8A3E-D98E3092C37A Q38921923-60325AB9-125F-479D-AB0D-07C6C57975FD Q38986743-50353204-3B5A-4769-8317-E487E89CE6D2

P2860

CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway.

http://www.wikidata.org/entity/Q33909085

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

CXCR6 induces prostate cancer ...... f rapamycin signaling pathway.

@ast

CXCR6 induces prostate cancer ...... f rapamycin signaling pathway.

@en

type

label

CXCR6 induces prostate cancer ...... f rapamycin signaling pathway.

@ast

CXCR6 induces prostate cancer ...... f rapamycin signaling pathway.

@en

prefLabel

CXCR6 induces prostate cancer ...... f rapamycin signaling pathway.

@ast

CXCR6 induces prostate cancer ...... f rapamycin signaling pathway.

@en

P1433

Q33909085-BA3464D8-88DB-4905-906D-532868AD4631

P1476

Q33909085-8A180B7C-71E2-4A41-9840-DF57053A3E16

P2093

Q33909085-0CAB2435-3DE5-4AED-ACF9-2705E4F12F9E

Q33909085-4ADD9588-7BD7-44FA-B9E9-67B368FA9399

Q33909085-55878DCA-ABD0-468E-9BF7-72F91EC5EDF0

Q33909085-ADCC3D08-FD4E-4A28-A8A3-BB11C0D920BD

P2860

Q33909085-0EDBBF2B-BBCC-4343-8A5B-967C22177FD9

Q33909085-13EEAF31-FFDA-455D-8B65-773EFCAE4046

Q33909085-14059AF1-CF1E-4F5F-9583-E2FDE179D843

Q33909085-1D5FA65D-9155-44E6-9E95-46A48452925B

Q33909085-2AF1F8A8-5AFF-49ED-86E0-043A0C9BA176

Q33909085-32DF3A3C-066A-414B-B773-9144F82E10C8

Q33909085-33100F84-3989-4707-897B-C5402980EAAC

Q33909085-3D14771C-490A-4E08-A7DA-BC226F7C2E44

Q33909085-51D999A9-91D5-451B-BFD2-AA72CFCB1CC2

Q33909085-52B57C2A-38C1-4900-A945-9F0ED61DD0A3

P304

Q33909085-14A613D7-1C43-4E1C-A3BC-9AE7FDBC0C62

P31

Q33909085-89D1AB71-258A-4513-9895-EE174B8F719D

P356

Q33909085-DF7117CA-E2D1-4F20-BF67-0B43DB544C54

P407

Q33909085-3C88D742-99DB-4D79-9089-955B7210A04A

P433

Q33909085-A88D04E1-E762-48CD-B759-900497BA501B

P478

Q33909085-80E76949-6324-4C4A-A6ED-CA770B16E87B

P50

Q33909085-169C1824-4DDE-471E-BB7A-C624D14779FD

Q33909085-1BCB13F9-7EA7-4B92-A67E-82D81B8A2F31

P577

Q33909085-8C4F9E89-1D1D-4308-9DAC-FBE14050C5D7

P698

Q33909085-E24A2644-FBAE-4B65-9616-947452D3C984

P932

Q33909085-1EEC736D-CB4A-4A2B-A198-1DCE20281CDC

P356

0008-5472.CAN-08-2780

P1433

Cancer Research

P1476

CXCR6 induces prostate cancer ...... f rapamycin signaling pathway.

@en

P2093

Alisa E Koch

http://www.w3.org/2001/XMLSchema#string

Jianhua Wang

http://www.w3.org/2001/XMLSchema#string

Jingchen Wang

http://www.w3.org/2001/XMLSchema#string

Yi Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of chemokine receptors in breast cancer metastasis

Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines

Expression cloning of new receptors used by simian and human immunodeficiency viruses

The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer

The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

Prospective identification of tumorigenic prostate cancer stem cells

Metastasis to bone: causes, consequences and therapeutic opportunities

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall.

P304

10367-10376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-2780

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

Russell S. Taichman

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19074906

http://www.w3.org/2001/XMLSchema#string

P932

2884407

http://www.w3.org/2001/XMLSchema#string